✦ LIBER ✦

9007 Randomized, double-blind phase II/III study of first-line paclitaxel (P) plus carboplatin (C) in combination with vorinostat or placebo in patients with advanced non-small-cell lung cancer (NSCLC)

✍ Scribed by Belani, C.; Ramalingam, S.; Kalemkerian, G.; Mok, T.; Rosell, R.; Ahn, M.J.; Sun, L.; Gates, M.; Lubiniecki, G.M.; Govindan, R.

Book ID: 122936797
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 46 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71720-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized phase II study of first-line

Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancer

✍ Niho, Seiji; Kunitoh, Hideo; Nokihara, Hiroshi; Horai, Takeshi; Ichinose, Yukito 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 408 KB

O-217 A randomized phase III trial of ge

O-217 A randomized phase III trial of gemcitabine (G) in combination with carboplatin (C) or paclitaxel (P) versus paclitaxel plus carboplatin in advanced (Stage IIIB, IV) Non-Small Cell Lung Cancer (NSCLC)

✍ Treat, Joe; Chandra, Belani P.; Edelman, Martin; Socinski, Mark; Gonin, R.; Ansa 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 170 KB

A phase II study of carboplatin and pacl

A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC)

✍ Giorgio, Carmelo Giannitto; Pappalardo, Alessandro; Russo, Antonio; Giuffrida, D 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 95 KB

A phase III randomized study of carbopla

A phase III randomized study of carboplatin and paclitaxel with or without amifostine in patients with non-small cell lung cancer (NSCLC)

✍ Belani, C.P; Ansari, R.H; Atkins, J.N; Hon, J.K; Modiano, M.R; Budd, T.G 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Weekly nab-Paclitaxel in Combination Wit

Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer: Final Results of a Phase III Trial

✍ Socinski, M. A.; Bondarenko, I.; Karaseva, N. A.; Makhson, A. M.; Vynnychenko, I 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 207 KB

A Randomized Phase II Study of Pemetrexe

A Randomized Phase II Study of Pemetrexed in Combination With Cisplatin or Carboplatin as First-Line Therapy for Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer

✍ Schuette, Wolfgang H.W.; Gröschel, Andreas; Sebastian, Martin; Andreas, Stefan; 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 534 KB